gadoxetic-acid-disodium has been researched along with iopromide* in 7 studies
7 other study(ies) available for gadoxetic-acid-disodium and iopromide
Article | Year |
---|---|
Are radio-contrast agents commonly used in discography toxic to the intact intervertebral disc tissue cells?
In the literature, there have been no studies showing clear results on how radio-contrast pharmaceuticals would affect intact disc tissue cells. In this context, it was aimed to evaluate the effects of iopromide and gadoxetic acid, frequently used in the discography, on intact lumbar disc tissue in pharmaco-molecular and histopathological level. Primary cell cultures were prepared from the healthy disc tissue of the patients operated in the neurosurgery clinic. Except for the control group, the cultures were incubated with the indicated radio-contrast agents. Cell viability, toxicity and proliferation indices were tested at specific time intervals. The cell viability was quantitatively analysed. It was also visually rechecked under a fluorescence microscope with acridine orange/propidium iodide staining. Simultaneously, cell surface morphology was analysed with an inverted light microscope, while haematoxylin and eosin (H&E) staining methodology was used in the histopathological evaluations. The obtained data were evaluated statistically. Unlike the literature, iopromide or gadoxetic acid did not have any adverse effects on the cell viability, proliferation and toxicity (P < 0.05). Although this study reveals that radio-contrast pharmaceuticals used in the discography, often used in neurosurgical practice, can be safely used, it should be remembered that this study was performed in an in vitro environment. Topics: Adult; Cell Survival; Contrast Media; Gadolinium DTPA; Humans; Intervertebral Disc; Intervertebral Disc Degeneration; Iohexol; Low Back Pain; Lumbar Vertebrae; Primary Cell Culture | 2019 |
Feasibility of semiautomated MR volumetry using gadoxetic acid-enhanced MRI at hepatobiliary phase for living liver donors.
To assess the feasibility of semiautomated MR volumetry using gadoxetic acid-enhanced MRI at the hepatobiliary phase compared with manual CT volumetry.. Forty potential live liver donor candidates who underwent MR and CT on the same day, were included in our study. Semiautomated MR volumetry was performed using gadoxetic acid-enhanced MRI at the hepatobiliary phase. We performed the quadratic MR image division for correction of the bias field inhomogeneity. With manual CT volumetry as the reference standard, we calculated the average volume measurement error of the semiautomated MR volumetry. We also calculated the mean of the number and time of the manual editing, edited volume, and total processing time.. The average volume measurement errors of the semiautomated MR volumetry were 2.35% ± 1.22%. The average values of the numbers of editing, operation times of manual editing, edited volumes, and total processing time for the semiautomated MR volumetry were 1.9 ± 0.6, 8.1 ± 2.7 s, 12.4 ± 8.8 mL, and 11.7 ± 2.9 s, respectively.. Semiautomated liver MR volumetry using hepatobiliary phase gadoxetic acid-enhanced MRI with the quadratic MR image division is a reliable, easy, and fast tool to measure liver volume in potential living liver donors. Topics: Adolescent; Adult; Contrast Media; Feasibility Studies; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Iohexol; Liver Transplantation; Living Donors; Magnetic Resonance Imaging; Middle Aged; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Detection of recurrent hepatocellular carcinoma on post-operative surveillance: comparison of MDCT and gadoxetic acid-enhanced MRI.
To compare the accuracy of multidetector computed tomography (MDCT) and gadoxetic acid-enhanced magnetic resonance imaging (MRI) for the detection of intrahepatic tumor recurrence after curative resection of hepatocellular carcinoma (HCC).. Fifty-six patients who underwent MDCT and gadoxetic acid-enhanced MRI for postoperative surveillance after resection of HCC were retrospectively analyzed; 26 patients had a recurrence (36 lesions) and 30 patients did not. Recurrent HCCs were confirmed by histological examinations in two, typical dynamic imaging findings on CT and/or MRI in 28, and by demonstration of growth or tumor staining on angiography on six. Two reviewers graded the confidence for the presence of recurrence on CT and MRI, using a five-point scale. The jackknife free-response receiver operating characteristic method was used to compare diagnostic performance. The accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated.. For 36 recurrent lesions, the figure of merit was significantly higher for MRI than MDCT for detecting recurrence for both reviewers (p < 0.005 for both reviewers). In lesion-by-lesion analysis, the sensitivity was significantly higher on MRI (100% for reviewer 1 and 97% for reviewer 2) than on MDCT (44.4% and 66.6%) for both reviewers (p < 0.005 for both reviewers). Also in patient-by-patient analysis, sensitivity was significantly higher on MRI (100% and 96.1%) than on MDCT (57.6% and 76.9%) for both reviewers (p < 0.05 for both reviewers).. Gadoxetic acid-enhanced MRI is superior to MDCT for detecting intrahepatic recurrence after curative resection of HCC. Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Iohexol; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Recurrence, Local; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2014 |
Imaging findings of primary malignant gastrointestinal stromal tumor of the liver.
A primary gastrointestinal stromal tumor (GIST) arising in the liver is extremely rare. In our case of GIST, CT and MRI showed a well-defined, weakly enhancing mass with a cystic component in the left lateral segment of the liver that showed homogeneous and avid (18)F-fluorodeoxyglucose ((18)F-FDG) accumulation on positron emission tomography/computed tomography (PET/CT). We herein present a rare case of primary malignant GIST of the liver presenting with peritoneal seeding on CT, gadoxetic acid-enhanced MRI and (18)F-FDG PET/CT. Topics: Aged; Contrast Media; Diagnosis, Differential; Diagnostic Imaging; Fluorodeoxyglucose F18; Gadolinium DTPA; Gastrointestinal Stromal Tumors; Humans; Image Enhancement; Iohexol; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Solitary necrotic nodules of the liver: cross-sectional imaging findings and follow-up in nine patients.
The purpose of our study was to retrospectively evaluate the sonographic, CT, and MRI findings (number, diameter, lobar location, depth from the hepatic capsule, and appearance of lesions) in a series of nine patients with pathologically proven solitary necrotic nodules of the liver and the natural evolution at follow-up in four of the nine patients.. Solitary necrotic nodules are usually small, solitary lesions, mainly located under the liver capsule of the right lobe. They are hypoechoic on sonography, hypoattenuating on CT, have low signal intensity on both T1- and T2-weighted MRI with lack of enhancement after IV contrast administration, and at follow-up have a tendency to show calcification and involution toward reduction in size. Topics: Adult; Aged; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Follow-Up Studies; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Iohexol; Iron; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Necrosis; Oxides; Retrospective Studies; Tomography, Spiral Computed; Ultrasonography, Doppler | 2008 |
A prototype liver-specific contrast medium for CT: preclinical evaluation of gadoxetic acid disodium, or Gd-EOB-DTPA.
The suitability of the hepatobiliary contrast medium gadoxetic acid disodium, or Gd-EOB-DTPA, for liver enhancement at computed tomography (CT) was studied.. CT attenuation levels at 120 kV were measured in samples of increasing concentrations of gadolinium (gadoxetic acid disodium) or iodine (iopromide) in aqueous solutions in vitro. In dogs, CT attenuation in the liver was measured up to 90 minutes after a single intravenous injection of 0.3, 0.5, and 0.7 mmol Gd/kg gadoxetic acid disodium (three dogs per dose group). In addition, three VX2 tumor-bearing rabbits were examined (0.7 mmol Gd/kg).. In vitro, the CT attenuation of gadolinium is 40% higher than that of iodine if calculated per milligram of gadolinium and iodine, respectively. In dogs, the median net increase in liver enhancement was 25, 33, and 43 HU with a dose of 0.3, 0.5, and 0.7 mmol Gd/kg, respectively. The gallbladder and bile ducts became clearly visible. In rabbits, liver enhancement of 25 HU provided improved visualization of the unenhanced tumor.. Because of the higher CT attenuation of gadolinium compared with iodine and because of its liver-specific uptake, gadoxetic acid disodium is a contrast medium that may improve diagnosis of pathologic liver conditions at CT. Topics: Animals; Cholangiography; Cholecystography; Contrast Media; Dogs; Gadolinium; Gadolinium DTPA; Iohexol; Liver; Organometallic Compounds; Pentetic Acid; Rabbits; Tomography, X-Ray Computed | 1997 |
Gd-EOB-DTPA and Yb-EOB-DTPA: two prototypic contrast media for CT detection of liver lesions in dogs.
To characterize computed tomographic (CT) attenuation of iodine, gadolinium, and ytterbium in vitro and to study CT liver enhancement after administration of two prototypic hepatocyte-directed contrast media in dogs.. Samples with increasing concentrations of iodine, gadolinium, and ytterbium were measured for CT attenuation in a water phantom at tube voltages of 80, 120, and 137 kV. Three groups of five adult beagle dogs each received a 0.5 mmol/kg dose of either gadoxetic acid disodium (gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid [EOB-DTPA]) or Yb-EOB-DTPA as intravenous infusions or Yb-EOB-DTPA as an intravenous bolus injection.. At 120 kV, in vitro CT attenuation of gadolinium and ytterbium exceeded that of iodine by 41% and 45%, respectively, when measured at equal mass concentrations (in milligrams per milliliter of saline). In dogs, CT liver enhancement values above the precontrast liver attenuation were 32.6 HU +/- 2.3, 31.4 HU +/- 1.1, and 33.4 HU +/- 5.2 after 0.5 mmol/kg Gd-EOB-DTPA or Yb-EOB-DTPA infusion or Yb-EOB-DTPA bolus, respectively. The values were not significantly different (P > .05). Both Gd-EOB-DTPA and Yb-EOB-DTPA provide excellent CT liver enhancement in dogs. CT liver enhancement is not significantly altered by either the absorbing element (gadolinium vs ytterbium) or the mode of application (infusion vs bolus). Topics: Animals; Contrast Media; Dogs; Gadolinium DTPA; Infusions, Intravenous; Injections, Intravenous; Iohexol; Liver; Pentetic Acid; Phantoms, Imaging; Tomography, X-Ray Computed | 1997 |